Skip to content

Faculty profile

wajd Alkabbani

Back to faculty
ResearcherSchool of PharmacyUniversity of Waterloo

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Waterloo directory, so their courses and email address may be missing. Find their university profile.

Latest papers

  • Beyond Glycemia: Entering the Era of Hard Outcomes for Continuous Glucose Monitoring.

    Diabetes care · 2026 · first author

  • Glucagon-Like Peptide-1 Based Therapies and the Risk of Severe Gastrointestinal Motility Adverse Events: A Cohort Study.

    Diabetes, obesity & metabolism · 2026 · first author

  • Safety of Sodium/Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes and CKD.

    American journal of kidney diseases : the official journal of the National Kidney Foundation · 2026

All 31 publications

Latest funding

  • Access, Equity, and Real-World Effectiveness of Continuous Glucose Monitoring in Adults with Type 2 Diabetes: A Multi-Provincial Canadian Study

    CIHR · 2025 · Nominated PI

    $481,950
All 1 grants and awards
Something wrong or missing on this profile? Suggest a correction